Literature DB >> 24710378

Tumor heterogeneity confounds and illuminates: a case for Darwinian tumor evolution.

Kornelia Polyak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24710378     DOI： 10.1038/nm.3518

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors:  José Baselga; Mario Campone; Martine Piccart; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun; J Thaddeus Beck; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; Zhiying Xu; Pabak Mukhopadhyay; David Lebwohl; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

Review 2.  Biological determinants of endocrine resistance in breast cancer.

Authors:  Elizabeth A Musgrove; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

3.  An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.

Authors:  Q X Zhang; A Borg; D M Wolf; S Oesterreich; S A Fuqua
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

4.  Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

Authors:  Shunqiang Li; Dong Shen; Jieya Shao; Robert Crowder; Wenbin Liu; Aleix Prat; Xiaping He; Shuying Liu; Jeremy Hoog; Charles Lu; Li Ding; Obi L Griffith; Christopher Miller; Dave Larson; Robert S Fulton; Michelle Harrison; Tom Mooney; Joshua F McMichael; Jingqin Luo; Yu Tao; Rodrigo Goncalves; Christopher Schlosberg; Jeffrey F Hiken; Laila Saied; Cesar Sanchez; Therese Giuntoli; Caroline Bumb; Crystal Cooper; Robert T Kitchens; Austin Lin; Chanpheng Phommaly; Sherri R Davies; Jin Zhang; Megha Shyam Kavuri; Donna McEachern; Yi Yu Dong; Cynthia Ma; Timothy Pluard; Michael Naughton; Ron Bose; Rama Suresh; Reida McDowell; Loren Michel; Rebecca Aft; William Gillanders; Katherine DeSchryver; Richard K Wilson; Shaomeng Wang; Gordon B Mills; Ana Gonzalez-Angulo; John R Edwards; Christopher Maher; Charles M Perou; Elaine R Mardis; Matthew J Ellis
Journal:  Cell Rep       Date:  2013-09-19       Impact factor: 9.423

Review 5.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

6.  D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer.

Authors:  Keren Merenbakh-Lamin; Noa Ben-Baruch; Adva Yeheskel; Addie Dvir; Lior Soussan-Gutman; Rinath Jeselsohn; Roman Yelensky; Myles Brown; Vincent A Miller; David Sarid; Shulamith Rizel; Baruch Klein; Tami Rubinek; Ido Wolf
Journal:  Cancer Res       Date:  2013-11-11       Impact factor: 12.701

7.  Estrogen receptor mutations in tamoxifen-resistant breast cancer.

Authors:  P S Karnik; S Kulkarni; X P Liu; G T Budd; R M Bukowski
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

8.  Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

Authors:  N Roodi; L R Bailey; W Y Kao; C S Verrier; C J Yee; W D Dupont; F F Parl
Journal:  J Natl Cancer Inst       Date:  1995-03-15       Impact factor: 13.506

9.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

10.  ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.

Authors:  Weiyi Toy; Yang Shen; Helen Won; Bradley Green; Rita A Sakr; Marie Will; Zhiqiang Li; Kinisha Gala; Sean Fanning; Tari A King; Clifford Hudis; David Chen; Tetiana Taran; Gabriel Hortobagyi; Geoffrey Greene; Michael Berger; José Baselga; Sarat Chandarlapaty
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330
View more
  33 in total

1.  A metric and workflow for quality control in the analysis of heterogeneity in phenotypic profiles and screens.

Authors:  Albert Gough; Tong Ying Shun; D Lansing Taylor; Mark Schurdak
Journal:  Methods       Date:  2015-11-04       Impact factor: 3.608

Review 2.  The Cellular Origin and Evolution of Breast Cancer.

Authors:  Mei Zhang; Adrian V Lee; Jeffrey M Rosen
Journal:  Cold Spring Harb Perspect Med       Date:  2017-03-01       Impact factor: 6.915

3.  Optical metabolic imaging quantifies heterogeneous cell populations.

Authors:  Alex J Walsh; Melissa C Skala
Journal:  Biomed Opt Express       Date:  2015-01-15       Impact factor: 3.732

Review 4.  Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.

Authors:  Li Yang; P Charles Lin
Journal:  Semin Cancer Biol       Date:  2017-08-03       Impact factor: 15.707

5.  Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.

Authors:  Zhi-Cheng Li; Hongmin Bai; Qiuchang Sun; Qihua Li; Lei Liu; Yan Zou; Yinsheng Chen; Chaofeng Liang; Hairong Zheng
Journal:  Eur Radiol       Date:  2018-03-21       Impact factor: 5.315

6.  Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.

Authors:  James W Rocco
Journal:  Head Neck Pathol       Date:  2015-03-25

7.  Genome-wide DNA copy number analysis and targeted transcriptional analysis of canine histiocytic malignancies identifies diagnostic signatures and highlights disruption of spindle assembly complex.

Authors:  Katherine Kennedy; Rachael Thomas; Jessica Durrant; Tao Jiang; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2019-04-23       Impact factor: 5.239

8.  HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models.

Authors:  Luke Whitesell; Sandro Santagata; Marc L Mendillo; Nancy U Lin; David A Proia; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

9.  Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.

Authors:  Jae Young So; Nicolas Skrypek; Howard H Yang; Anand S Merchant; George W Nelson; Wei-Dong Chen; Hiroki Ishii; Jennifer M Chen; Gangqing Hu; Bhagelu R Achyut; Esther C Yoon; Liying Han; Chuanshu Huang; Margaret C Cam; Keji Zhao; Maxwell P Lee; Li Yang
Journal:  Cancer Res       Date:  2020-04-07       Impact factor: 12.701

10.  Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

Authors:  L De Mattos-Arruda; B Weigelt; J Cortes; H H Won; C K Y Ng; P Nuciforo; F-C Bidard; C Aura; C Saura; V Peg; S Piscuoglio; M Oliveira; Y Smolders; P Patel; L Norton; J Tabernero; M F Berger; J Seoane; J S Reis-Filho
Journal:  Ann Oncol       Date:  2014-07-09       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.